Skip to main content

Table 4 Mortality Predictors of hemodialysis patients in Kinshasa, with Cox regression

From: Impact of residual urine volume decline on the survival of chronic hemodialysis patients in Kinshasa

Variables

Univariate Analysis

Multivariate Analysis

 

HR

95,0%CI

p

Adjusted HR

95,0%CI

p

Financing (not secured vs yes)

3.33

2.16

5.15

<0.001

2.23

1.11

4.46

0.024

Weight *(Kg)

0.98

0.96

0.99

0.005

1.02

0.99

1.04

0.179

Decline RUV (≥25 vs <25 ml/day/month)

4.56

2.87

7.23

<0.001

5.35

2.73

10.51

<0.001

Hypervolemia (yes vs no)

2.79

1.90

4.09

<0.001

2.00

1.17

3.40

0.011

ACE inhibitor

2.53

1.71

3.74

<0.001

2.48

1.40

4.40

0.002

Beta blocker

2.56

1.37

4.79

0.003

4.04

1.42

11.54

0.009

Catheter vs AVF

18.84

5.89

60.26

<0.001

6.26

1.71

22.85

0.006

Weekly hours of HD ≤8 vs ≥12

1.56

1.06

2.31

0.024

1.70

0.91

3.17

0.095

Charlson Index*

1.08

1.01

1.15

0.022

1.01

0.94

1.09

0.812

Kaliemia*, mEq/l

1.17

1.02

1.35

0.027

1.12

0.92

1.35

0.272

Serum albumine*, g/l

0.94

0.92

0.97

<0.001

0.93

0.89

0.96

<0.001

Hemoglobin*, g/dl

0.731

0.66

0.81

<0.001

0.73

0.63

0.84

<0.001

  1. Abbreviations: RUV: residual urine volume, ACE: angiotensin conversion enzyme inhibitor, AVF: arterio-venous fistula
  2. *,quantitative variable